Klaviyo (NYSE:KVYO) Shares Down 7.5% - Time to Sell?

Key Points

• Shares fell 7.5% intraday to about $20.88 on Tuesday, trading well below its 50‑day ($28.56) and 200‑day ($29.34) moving averages and on sharply lighter volume (≈208k vs. avg 3.52M).
• Analysts maintain a “Moderate Buy” consensus with a mean price target of $41.05, though several firms have recently trimmed targets and opinions range from Strong Buy to Sell.
• Fundamentals are mixed: Klaviyo beat revenue and EPS estimates with revenue up 32.2%, but it still has a negative net margin (−5.7%) and negative ROE, and insiders sold roughly 1.86M shares (~$52.8M) last quarter while owning about 49.9% of the company.

Klaviyo, Inc. (NYSE:KVYO - Get Free Report) shares dropped 7.5% during mid-day trading on Tuesday . The stock traded as low as $21.10 and last traded at $20.8780. Approximately 208,448 shares were traded during trading, a decline of 94% from the average daily volume of 3,517,636 shares. The stock had previously closed at $22.56.

Wall Street Analyst Weigh In

KVYO has been the subject of a number of research analyst reports. KeyCorp lowered their target price on Klaviyo from $50.00 to $45.00 and set an "overweight" rating for the company in a research note on Thursday, November 6th. Jefferies Financial Group raised shares of Klaviyo to a "strong-buy" rating in a research report on Wednesday, October 22nd. William Blair reiterated an "outperform" rating on shares of Klaviyo in a research note on Monday, November 17th. The Goldman Sachs Group decreased their price target on Klaviyo from $48.00 to $41.00 and set a "buy" rating for the company in a research note on Friday, November 7th. Finally, Macquarie dropped their target price on Klaviyo from $37.00 to $30.00 and set a "neutral" rating for the company in a report on Tuesday, November 11th. Two investment analysts have rated the stock with a Strong Buy rating, eighteen have issued a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Klaviyo has an average rating of "Moderate Buy" and a consensus price target of $41.05.

Klaviyo Price Performance

The business's 50 day moving average price is $28.56 and its 200 day moving average price is $29.34. The stock has a market capitalization of $6.07 billion, a P/E ratio of -84.09 and a beta of 1.08.

Klaviyo (NYSE:KVYO - Get Free Report) last announced its earnings results on Wednesday, November 5th. The company reported $0.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.14 by $0.04. The firm had revenue of $310.88 million for the quarter, compared to analysts' expectations of $299.93 million. Klaviyo had a negative net margin of 5.70% and a negative return on equity of 1.00%. The business's revenue was up 32.2% compared to the same quarter last year. During the same period in the prior year, the company earned $0.15 EPS. As a group, analysts forecast that Klaviyo, Inc. will post 0.04 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director Ed Hallen sold 117,550 shares of the firm's stock in a transaction on Wednesday, December 17th. The shares were sold at an average price of $30.36, for a total transaction of $3,568,818.00. Following the sale, the director directly owned 133,624 shares in the company, valued at $4,056,824.64. This trade represents a 46.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Andrew Bialecki sold 167,926 shares of the firm's stock in a transaction dated Tuesday, January 20th. The shares were sold at an average price of $24.16, for a total value of $4,057,092.16. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 1,862,901 shares of company stock worth $52,846,182 over the last quarter. Corporate insiders own 49.92% of the company's stock.

Institutional Investors Weigh In On Klaviyo

Several hedge funds have recently added to or reduced their stakes in the business. Royal Bank of Canada boosted its holdings in Klaviyo by 59.4% in the first quarter. Royal Bank of Canada now owns 10,008 shares of the company's stock valued at $303,000 after purchasing an additional 3,730 shares during the last quarter. Amundi boosted its position in Klaviyo by 109.7% in the 1st quarter. Amundi now owns 14,361 shares of the company's stock valued at $400,000 after buying an additional 7,514 shares during the last quarter. AQR Capital Management LLC bought a new position in Klaviyo in the first quarter valued at approximately $359,000. Woodline Partners LP increased its stake in Klaviyo by 54.5% in the 1st quarter. Woodline Partners LP now owns 12,419 shares of the company's stock valued at $376,000 after buying an additional 4,379 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Klaviyo by 40.9% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 148,158 shares of the company's stock worth $4,483,000 after purchasing an additional 42,980 shares during the last quarter. 45.43% of the stock is owned by hedge funds and other institutional investors.

About Klaviyo

Klaviyo, Inc is a cloud-based marketing automation platform that enables businesses to leverage customer data for targeted email and SMS campaigns. The company's platform centralizes first-party data from various sources—including e-commerce storefronts, websites, and CRM systems—to help organizations deliver personalized marketing across the customer lifecycle. Klaviyo's core offerings include segmented email marketing, automated messaging workflows, and performance analytics designed to drive customer engagement and revenue growth.

The platform provides a suite of tools for campaign creation and management, including drag-and-drop email and SMS builders, dynamic content rendering, and A/B testing capabilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.